Center for Scientific Review; Notice of Closed Meetings, 72497 [2023-23229]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 202 / Friday, October 20, 2023 / Notices
Federal Register on October 4, 2023, 88
FR 68640 FR Doc No. 2023–21888.
This meeting is being amended to
change the meeting date from November
21, 2023, to November 8, 2023, and the
time from 9:00 a.m.–5:00 p.m. to 9:30
a.m.–4:00 p.m. The meeting is closed to
the public.
Dated: October 17, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–23230 Filed 10–19–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
ddrumheller on DSK120RN23PROD with NOTICES1
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Topics in Disease Control and
Applied Immunology.
Date: November 16, 2023.
Time: 11 a.m. to 8 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Marcus Ferrone,
PHARMD, Scientific Review Officer, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 402–2371, marcus.ferrone@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Molecular Genetics and Genomics.
Date: November 16, 2023.
Time: 1 p.m. to 7 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sarita Kandula Sastry,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
VerDate Sep<11>2014
18:20 Oct 19, 2023
Jkt 262001
Health, 6701 Rockledge Drive, Bethesda, MD
20782, 301–402–4788, sarita.sastry@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Topics in
Drug Discovery and Molecular
Pharmacology.
Date: November 17, 2023.
Time: 10 a.m. to 9 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Subhamoy Pal, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 594–0926, subhamoy.pal@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Respiratory Sciences.
Date: November 17, 2023.
Time: 10 a.m. to 8 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Stefania Senger, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 867–5309, stefania.senger@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–22–
180: Maximizing Investigators’ Research
Award (R35-Clinical Trial Optional).
Date: November 20, 2023.
Time: 10 a.m. to 9 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jessica Smith, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, 301.402.3717, jessica.smith6@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Drug Discovery and Development.
Date: November 20–21, 2023.
Time: 10 a.m. to 8 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sergei Ruvinov, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4158,
MSC 7806, Bethesda, MD 20892, 301–435–
1180, ruvinser@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Topics in
Health Services Research.
Date: November 28, 2023.
Time: 9 a.m. to 1:30 p.m.
Agenda: To review and evaluate grant
applications.
PO 00000
Frm 00079
Fmt 4703
Sfmt 9990
72497
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Angela Denise Thrasher,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1000J,
Bethesda, MD 20892, (301) 480–6894,
thrasherad@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Cellular and
Molecular Aspects of the Blood-Brain Barrier
and Neurovascular System and Therapeutic
Strategies.
Date: December 1, 2023.
Time: 9 a.m. to 7 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jacek Topczewski, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1002A1,
Bethesda, MD 20892, (301) 594–7574,
topczewskij2@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Program
Projects: Drug Development.
Date: December 4, 2023.
Time: 11 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kenneth Ryan, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3218,
MSC 7717, Bethesda, MD 20892, 301–435–
0229, kenneth.ryan@nih.hhs.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Glial Biology, Neurodegeneration
and Neuroregulation.
Date: December 4, 2023.
Time: 1 p.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Prithi Rajan, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 435–1042, prithi.rajan@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS).
Dated: October 17, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–23229 Filed 10–19–23; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\20OCN1.SGM
20OCN1
]]>Agencies
[Federal Register Volume 88, Number 202 (Friday, October 20, 2023)]
[Notices]
[Page 72497]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-23229]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Topics in Disease Control and Applied
Immunology.
Date: November 16, 2023.
Time: 11 a.m. to 8 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Marcus Ferrone, PHARMD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 402-2371,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Molecular Genetics and Genomics.
Date: November 16, 2023.
Time: 1 p.m. to 7 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sarita Kandula Sastry, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20782, 301-402-4788,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Topics in Drug Discovery and Molecular Pharmacology.
Date: November 17, 2023.
Time: 10 a.m. to 9 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Subhamoy Pal, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892, (301) 594-0926,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Respiratory Sciences.
Date: November 17, 2023.
Time: 10 a.m. to 8 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Stefania Senger, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 867-5309,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR-22-180: Maximizing Investigators' Research Award (R35-
Clinical Trial Optional).
Date: November 20, 2023.
Time: 10 a.m. to 9 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jessica Smith, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892, 301.402.3717,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Drug Discovery and Development.
Date: November 20-21, 2023.
Time: 10 a.m. to 8 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sergei Ruvinov, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4158, MSC 7806, Bethesda, MD
20892, 301-435-1180, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Topics in Health Services Research.
Date: November 28, 2023.
Time: 9 a.m. to 1:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Angela Denise Thrasher, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1000J, Bethesda, MD 20892, (301)
480-6894, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Cellular and Molecular Aspects of the Blood-Brain Barrier and
Neurovascular System and Therapeutic Strategies.
Date: December 1, 2023.
Time: 9 a.m. to 7 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jacek Topczewski, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1002A1, Bethesda, MD 20892, (301)
594-7574, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Program Projects: Drug Development.
Date: December 4, 2023.
Time: 11 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kenneth Ryan, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3218, MSC 7717, Bethesda, MD 20892, 301-435-
0229, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Glial Biology, Neurodegeneration and
Neuroregulation.
Date: December 4, 2023.
Time: 1 p.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Prithi Rajan, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892, (301) 435-1042,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS).
Dated: October 17, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-23229 Filed 10-19-23; 8:45 am]
BILLING CODE 4140-01-P
